AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 DEC 2 - (NewsRx.com & NewsRx.net) -- Postmenopausal hormone therapy use appears to attenuate the increase in a bone resorption marker associated with a calciuric diet, study data indicate.
Researchers in Ireland studied "the influence of a high-sodium, high-protein diet on bone metabolism in postmenopausal women (aged 49-60 years) stratified by hormone replacement therapy (HRT) use."
"In a crossover trial, 18 women [n=8 HRT users (+HRT) and n=10 nonusers (-HRT)] were randomly assigned to a diet high in protein (90 g/day) and sodium (180 mmol/day) (calciuric diet) or a diet moderate in protein (70 g/day) and low in sodium (65 mmol/day) for 4 weeks followed by crossover to alternative dietary regimen for a further 4 weeks," reported M. Harrington and colleagues, National University of Ireland.
Measurements revealed that "the calciuric diet significantly (p
"While the calciuric diet increased urinary N-telopeptide crosslinks of collagen (by about 25%, p=0.003) in the -HRT group, it had no effect in the +HRT group," Harrington and colleagues said.
"It appears that postmenopausal HRT use attenuates the ...
Source: HighBeam Research, HT attenuates increase in bone resorption marker associated with...